Search results for "Carbohydrate Sequence"

showing 10 items of 60 documents

Specificity of human natural antibodies referred to as anti-Tn

2020

International audience; To understand the role of human natural IgM known as antibodies against the carbohydrate epitope Tn, the antibodies were isolated using GalNAcα−Sepharose affinity chromatography, and their specificity was profiled using microarrays (a glycan array printed with oligosaccharides and bacterial polysaccharides, as well as a glycopeptide array), flow cytometry, and inhibition ELISA. The antibodies bound a restricted number of GalNAcα-terminated oligosaccharides better than the parent monosaccharide, e.g., 6-O-Su-GalNAcα and GalNAcα1−3Galβ1−3(4)GlcNAcβ. The binding with several bacterial polysaccharides that have no structural resemblance to the affinity ligand GalNAcα was…

0301 basic medicineGlycanGlycansImmunologyTn antigenAntibody Affinity[SDV.CAN]Life Sciences [q-bio]/CancerAnti-Glycan antibodiesEpitopeAntigen-Antibody ReactionsEpitopesJurkat Cells03 medical and health sciences0302 clinical medicineAffinity chromatography[SDV.CAN] Life Sciences [q-bio]/CancerAntibody SpecificityNeoplasmsTn antigenHumansAntigens Tumor-Associated CarbohydrateAmino Acid SequenceMolecular BiologyPeptide sequenceCancerbiologyChemistryBacterial polysaccharideImmunity Innate3. Good health030104 developmental biologyCarbohydrate SequenceImmunoglobulin MBiochemistryNatural antibodiesbiology.proteinParatopeAntibody030215 immunology
researchProduct

The Complete Structure of the Core Oligosaccharide from Edwardsiella tarda EIB 202 Lipopolysaccharide

2017

The chemical structure and genomics of the lipopolysaccharide (LPS) core oligosaccharide of pathogenic Edwardsiella tarda strain EIB 202 were studied for the first time. The complete gene assignment for all LPS core biosynthesis gene functions was acquired. The complete structure of core oligosaccharide was investigated by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy, electrospray ionization mass spectrometry MSn, and matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. The following structure of the undecasaccharide was established: The heterogeneous appearance of the core oligosaccharide structure was due to the partial lack of β-d-Galp and the replace…

0301 basic medicineLipopolysaccharidesMagnetic Resonance SpectroscopyChemical structureElectrospray ionization030106 microbiologyOligosaccharidesTandem mass spectrometryMass spectrometry<i>Edwardsiella tarda</i>; core oligosaccharide; MALDI-TOF MS; ESI MS<sup>n</sup>; NMR; genomicESI MSnCatalysisArticleInorganic Chemistrylcsh:Chemistrycore oligosaccharidegenomic03 medical and health scienceschemistry.chemical_compoundBiosynthesisTandem Mass SpectrometryBacterial geneticsMALDI-TOF MSPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5Edwardsiella tardaSpectroscopyGenètica bacterianabiologyChemistryOrganic ChemistryEdwardsiella tardaGeneral MedicineNuclear magnetic resonance spectroscopybiology.organism_classificationNMRComputer Science ApplicationsMatrix-assisted laser desorption/ionization030104 developmental biologyBiochemistrylcsh:Biology (General)lcsh:QD1-999Carbohydrate SequencePathogenic bacteriaSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationBacteris patògensInternational Journal of Molecular Sciences
researchProduct

The O-antigen of Plesiomonas shigelloides serotype O36 containing pseudaminic acid

2016

The structure of the repeating unit of O-antigen of Plesiomonas shigelloides serotype O36 has been investigated by 1H and 13C NMR spectroscopy, matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry and chemical methods. The new structure of trisaccharide has been established: →4)-β-Pse5Ac7(R3Hb)-(2 → 4)-β-D-Galp-(1 → 3)-β-D-GlcpNAc-(1→ These trisaccharide O-antigen units substitute the core undecasaccharide at C-4 of the β-D-GlcpNAc residue. The core oligosaccharide and lipid A are identical with these of the serotype O17 (PCM 2231) (Maciejewska, A., Lukasiewicz, J., Kaszowska, M., Jachymek, W., Man-Kupisinska, A.; Lugowski, C. Mar. Drugs.2013, 11 (2), 440–454; Lukasi…

0301 basic medicineSerotypeMagnetic Resonance SpectroscopyStereochemistryMass spectrometrySerogroupBiochemistryAnalytical ChemistryLipid A03 medical and health sciencesResidue (chemistry)AntigenMALDI-TOF MSTrisaccharidechemistry.chemical_classification030102 biochemistry & molecular biologybiologyChemistryOrganic ChemistryO AntigensGeneral MedicineO-antigenbiology.organism_classificationPlesiomonas shigelloidesNMRMatrix-assisted laser desorption/ionization030104 developmental biologyBiochemistryCarbohydrate SequencePlesiomonas shigelloidesPlesiomonasCarbohydrate Research
researchProduct

The 9-O-acetylated disialosyl carbohydrate sequence of CDw60 is a marker on activated human B lymphocytes

1998

Gangliosides with a terminal 9-O-acetylated disialosyl group (CDw60 structures) show a restricted surface expression on human leukocytes. Hithereto, they have only been detected on subpopulations of human T lymphocytes. Using the defined CDw60 antibody UM4D4 and two new antibodies with preferential CDw60 activities, F6 and Z17, we demonstrate for the first time that CDw60 is an activation marker on human B lymphocytes. In vitro phorbol ester-stimulated human peripheral blood B lymphocytes as well as in vivo activated tonsillar B lymphocytes became CDw60 positive. CDw60 expression of these cells exceeds that of resting and activated T-lymphocytes.

AdultAntigens Differentiation T-Lymphocytemedicine.drug_classMolecular Sequence DataImmunologyLymphocyte ActivationMonoclonal antibodyStructure-Activity Relationshipchemistry.chemical_compoundAntigenAntigens CDPolysaccharidesIn vivomedicineHumansImmunology and AllergyStructure–activity relationshipB-LymphocytesbiologyAntibodies MonoclonalAcetylationMiddle AgedMolecular biologyIn vitroCarbohydrate SequenceBiochemistrychemistryAcetylationbiology.proteinPhorbolAntibodyBiomarkersImmunology Letters
researchProduct

Subtypes of non-transformed human mammary epithelial cells cultured in vitro: histo-blood group antigen H type 2 defines basal cell-derived cells.

1993

Normal (non-transformed) human mammary epithelial cell lines derived from reduction mammoplasties were analyzed by immunocytochemistry with more than 80 monoclonal antibodies (mAbs) and other specific reagents to tissue-specific and developmentally regulated antigens at different passage levels. A subpopulation of poorly differentiated, proliferating epithelial cells, corresponding to the 'selected' cell type of late passages, is shown to be characterized by a new marker, the histo-blood group antigen H type 2, probably carried on a membrane-bound glycolipid. These cells also express a number of other onco-developmental carbohydrate antigens [Le(y), Le(x), sialosyl-Le(a), precursor of Thoms…

AdultCancer ResearchCell typeIsoantigensmedicine.drug_classImmunocytochemistryMolecular Sequence DataBiologyMonoclonal antibodyEpitopeEpitheliumCell LineCytokeratinAntigenAntigens NeoplasmmedicineHumansElectrophoresis Gel Two-DimensionalBreastMolecular BiologyThomsen-Friedenreich AntigenEpithelial CellsCell BiologyMolecular biologyImmunohistochemistryClone CellsCarbohydrate SequenceCell cultureFemaleDevelopmental BiologyDifferentiation; research in biological diversity
researchProduct

Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry

2011

Morbus Fabry is a hereditary metabolic disorder with low prevalence and late clinical manifestation. A defect in the α-galactosidase gene leads to lysosomal accumulation of the glycolipid globotriaosylceramide (Gb3). Gb3 may be used for monitoring of enzyme replacement therapy (ERT), but diagnostic sensitivity is limited. Recently, globotriaosylsphingosine (lysoGb3) was introduced as a promising new marker with significantly better sensitivity. For Fabry diagnosis, clinical studies and possible therapy monitoring, we established a fast and reliable LC-MS/MS assay for quantification of lysoGb3 in human plasma. Protein precipitation and glycolipid extraction from EDTA plasma was performed usi…

AdultMaleAnalyteMolecular Sequence DataClinical BiochemistryGlobotriaosylceramideChemical FractionationTandem mass spectrometryBiochemistryHigh-performance liquid chromatographyAnalytical Chemistrychemistry.chemical_compoundTandem Mass SpectrometrymedicineHumansProtein precipitationDerivatizationChromatography High Pressure LiquidSphingolipidsChromatographyElutionTrihexosylceramidesReproducibility of ResultsCell BiologyGeneral Medicinemedicine.diseaseFabry diseaseCarbohydrate SequencechemistryCase-Control StudiesLinear ModelsFabry DiseaseFemaleGlycolipidsBiomarkersJournal of Chromatography B
researchProduct

Characterization of epitopes recognized by Candida factor 1 and 9 antisera by use of Saccharomyces cerevisiae mnn mutants

1993

The use of Saccharomyces cerevisiae mnn mutants has facilitated the study of the epitopes recognized by antisera against several antigenic factors of the genus Candida (Candida Check; Iatron Laboratories, Tokyo, Japan). We have taken advantage of the very well characterized structure of the mannans of the different mnn mutants to compare their reactivities with the factor antisera used in the identification of different species of the genus Candida. The results of this study provide evidence that one of the antigenic determinants recognized by factor 1 antisera is the O-linked mannose chains of the cell wall mannoproteins, while that recognized by factor 9 antiserum is the alpha 1-6-linked …

AgglutinationAntigenicityAntigens FungalMolecular Sequence DataImmunologyMutantSaccharomyces cerevisiaeMannoseEnzyme-Linked Immunosorbent AssaySaccharomyces cerevisiaeBiologyMicrobiologyEpitopeMicrobiologyMannansEpitopeschemistry.chemical_compoundAntigenAnimalsAntibodies FungalCandidaMannanAntiserumImmune Serabiology.organism_classificationInfectious DiseasesCarbohydrate SequenceBiochemistrychemistryMutationParasitologyRabbitsResearch ArticleInfection and Immunity
researchProduct

Triterpene saponins from the roots ofAmpelozizyphus amazonicus

1992

A new triterpene saponin was isolated from the roots of Ampelozizyphus amazonicus together with the known 3-O-beta-D-glucopyranosyl-20-O-alpha-L-rhamnopyranosyljujubogenin and the known triterpenes melaleucic acid, 3 beta,27 alpha-dihydroxylup-20(29)-en-28 beta-oic acid, betulinic acid, betulin, lupeol. The structure of this saponin was elucidated as 3-O-[beta-D-glucopyranosyl(1----2)alpha-L-arabinopyranosyl]- 20-O-alpha-L-rhamnopyranosyljujubogenin by spectral analysis and chemical transformations.

AmpelozizyphusMagnetic Resonance SpectroscopyStereochemistryMolecular Sequence DataSaponinPlant ScienceHorticultureBiochemistryTerpenechemistry.chemical_compoundTriterpeneBetulinic acidMolecular BiologyLupeolchemistry.chemical_classificationPlants MedicinalBetulinMolecular StructurebiologyGeneral MedicineSaponinsbiology.organism_classificationTriterpenesCarbohydrate SequencechemistryRhamnaceaePhytochemistry
researchProduct

Steroidal saponins from the roots of Smilax aspera subsp. mauritanica

2008

Two new steroidal saponins (1, 2) were isolated from the roots of Smilax aspera subsp. mauritanica (POIR.) ARCANG. (Liliaceae), together with the known curillin G (3), asparagoside E (4), asparoside A (5), asparoside B (6) and the phenolic compound resveratrol (7). Their structures were established mainly on the basis of 600 MHz 2D-NMR spectral data. 3 exhibited antifungal activity against the human pathogenic yeasts Candida albicans, C. glabrata and C. tropicalis (minimum inhibitory concentrations of 25, 25 and 50 microg/ml, respectively) whereas the other compounds were inactive.

AntifungalSpectrometry Mass Electrospray IonizationAntifungal AgentsMagnetic Resonance SpectroscopySpectrophotometry Infraredmedicine.drug_classMolecular Sequence DataPharmaceutical ScienceMicrobial Sensitivity TestsSpectrometry Mass Fast Atom BombardmentResveratrolPlant RootsAnalytical Chemistrychemistry.chemical_compoundDrug DiscoveryBotanymedicineCandida albicansSpectral dataSmilax asperaCandidaPharmacologybiologyTraditional medicineLiliaceaeHydrolysisOrganic ChemistryFungiGeneral ChemistryGeneral MedicineSaponinsbiology.organism_classificationKetoconazoleCarbohydrate SequenceComplementary and alternative medicinechemistrySmilaxMolecular MedicineSteroidsPlanta Medica
researchProduct

Glycosyl azides as building blocks in convergent syntheses of oligomeric lactosamine and Lewisx saccharides

1997

Abstract Oligosaccharides containing type 2 lactosamine repeating units, e.g. neo-lacto-octaose and trimeric Lewis x derivatives, are constructed using neo-lactosamine azide building blocks. The azido group provides a favorable protection of the anomeric position which is stable to versatile protecting group manipulations and glycosylation reactions. On the other hand, glycosyl azides can be converted into glycosyl fluorides via a 1,3-dipolar cycloaddition with di- tert -butyl-acetylenedicar☐ylate and subsequent treatment of the resulting N -glycosyl triazoles with hydrogen fluoride-pyridine complex. Activation of the lactosamine fluorides with Lewis acids affords the possibility to extend …

AzidesMagnetic Resonance SpectroscopyGlycosylationChemistryStereochemistryMolecular Sequence DataOrganic ChemistryClinical BiochemistryChemical glycosylationDisaccharideLewis X AntigenPharmaceutical ScienceAmino SugarsBiochemistrychemistry.chemical_compoundCarbohydrate SequenceDrug DiscoveryCarbohydrate ConformationMolecular MedicineGlycosylLewis acids and basesAzideGlycosyl donorProtecting groupMolecular BiologyBioorganic &amp; Medicinal Chemistry
researchProduct